Skip to content
Peter Attia MDPeter Attia MD

#161 - AMA #23 [sneak peek]: All Things Nicotine: benefits, risks, and mechanisms of action

Sign up to receive Peter's email newsletter: https://bit.ly/4c602k2 In this “Ask Me Anything” (AMA) episode, Peter and Bob dive deep into nicotine, a complicated and interesting molecule that has effects on both the brain and the body. They analyze the results of the studies that describe nicotine’s cognitive benefits and potential for inducing weight loss. They talk about a smoking cessation technique called nicotine replacement therapy and give a full breakdown of the various routes of administration, dosing, and safety. Finally, they explore the fascinating and counterintuitive observation that cigarette smokers are less likely to get a severe case of COVID-19. In this sneak peek, we discuss: 00:00:00 - Intro 00:00:10 - How Peter first became interested in the potential benefits of nicotine 00:06:00 - Untangling nicotine from tobacco 00:09:50 - Nicotine replacement therapy (NRT) for quitting smoking: products, protocols, and a review of the literature 00:16:40 - The cognitive benefits of nicotine: Overview of the literature This is a special sneak peek of AMA #23. To view the full video, you'll want to become a podcast subscriber. You can subscribe to the podcast and learn more about all the subscriber benefits: https://peterattiamd.com/subscribe. In the full episode, we also discuss: -Where nicotine has the most positive impact on cognition -Possible mechanisms conferring the benefits of nicotine -How modafinil and other nootropics compare to nicotine -How nicotine may induce weight loss -Relationship between smoking and COVID-19: Analyzing the observation that smoking appears protective against COVID-19 -Breakdown of the various nicotine replacement therapies: route of administration, dosing, and safety -Concluding thoughts on nicotine: use cases, addictive properties, and more Show notes page: https://peterattiamd.com/ama23 -------- About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://peterattiamd.com Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle

Peter AttiahostBobhost
May 10, 202120mWatch on YouTube ↗

At a glance

WHAT IT’S REALLY ABOUT

Peter Attia and Bob Explore Nicotine's Benefits, Safety, and Role in Quitting Smoking

  1. Peter Attia describes his roughly 11-year personal experiment with nicotine gum and, more recently, nicotine pouches, saying he found them helpful for focus and never felt addicted.
  2. Bob explains that tobacco is a nightshade plant containing 1% to 3% nicotine by dry weight, and that nicotine is not on the lists of carcinogens even though at least 69 chemicals in tobacco are.
  3. The pair discuss nicotine replacement therapy, noting that a Cochrane review found high-quality evidence it raises quit success by 50% to 60% in relative terms, but that absolute six-month quit rates stay low.
  4. Attia questions why NRT does not work better and speculates that the fast delivery of inhaled smoke is hard for slower products to match, while Bob also raises the oral fixation and different routes of administration.
  5. The episode is a teaser that ends just as the discussion turns to cognitive benefit studies, before pivoting to membership promotion.

IDEAS WORTH REMEMBERING

5 ideas

Nicotine is distinct from tobacco's harms

Bob notes that nicotine is not among the roughly 69 carcinogens identified in tobacco, and that the US Surgeon General found inadequate evidence of a causal link between nicotine and cancer.

Nicotine's addictiveness is what links it to tobacco

Attia says nicotine has interesting benefits but that its addictive quality is what brings people back to tobacco, even though the molecule itself does not cause cancer.

Relative risk numbers can mislead

Attia stresses that a 50% to 60% relative increase in quitting sounds large, but because the absolute six-month quit rate is only about 3% to 5%, NRT adds just a couple of percentage points.

NRT is a weak tool against smoking

Attia says he does not understand why the improvement is not far larger, and suggests that nothing matches the rush from inhaling smoke across the lung's surface area.

Delivery route shapes the nicotine experience

Attia says pouches and lozenges bypass the liver and act faster, and Bob says gum can cause nausea if chewed rather than parked in the mouth.

WORDS WORTH SAVING

5 quotes

if you could strip away the addictive nature of nicotine, and we'll get into that a little bit more, the actual molecule was quite interesting

— Peter Attia

you could read the headline and say, "Wow, nicotine replacement therapy increases your odds of quitting by 50% to 60%," and that sounds like an awfully big number, but you have to always ask the question, what does that mean at an absolute level?

— Peter Attia

If you're a smoker and you're interested in longevity, uh, there's harder to find a lower hanging piece of fruit than smoking cessation as you move to improve someone's health.

— Peter Attia

nicotine makes up, uh, it says about 1% to 3% of the dry weight of tobacco, whereas these nightshades, it's like millionths of a percent, very trace amounts.

— Bob

the likelihood that it has any cancer-causing properties is, is approaching epsilon if not zero.

— Peter Attia

Personal experience with nicotine gum and pouchesNicotine versus tobaccoCarcinogens in tobacco smokeNicotine replacement therapy productsRelative versus absolute quit ratesRoutes of administration and speed of deliveryCognitive benefits of nicotine

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.

iOSAndroidClaudeChromeChatGPTComing soon